PL400683A1 - Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pylku traw PHL P4 - Google Patents

Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pylku traw PHL P4

Info

Publication number: PL400683A1
Authority: PL; Poland
Prior art keywords: dna; encoding; phl; poaceae; polypeptide
Prior art date: 2002-06-25

Application number

PL400683A

Other languages

English (en)

Other versions

PL219272B1 (pl

Inventor

Helmut Fiebig

Andreas Nandy

Roland Suck

Oliver Cromwell

Arnd Petersen

Wolf-Meinhard Becker

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-25

Filing date

2003-06-11

Publication date

2013-02-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL400683(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-06-11 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2013-02-04 Publication of PL400683A1 publication Critical patent/PL400683A1/pl

2015-04-30 Publication of PL219272B1 publication Critical patent/PL219272B1/pl

Links

238000000034 method Methods 0.000 title abstract 2
108091028043 Nucleic acid sequence Proteins 0.000 title 1
239000013574 grass pollen allergen Substances 0.000 title 1
108020004414 DNA Proteins 0.000 abstract 7
229920001184 polypeptide Polymers 0.000 abstract 4
102000004196 processed proteins & peptides Human genes 0.000 abstract 4
108090000765 processed proteins & peptides Proteins 0.000 abstract 4
241000209504 Poaceae Species 0.000 abstract 3
239000012634 fragment Substances 0.000 abstract 3
239000013566 allergen Substances 0.000 abstract 2
230000003266 anti-allergic effect Effects 0.000 abstract 2
230000002519 immonomodulatory effect Effects 0.000 abstract 2
108020004705 Codon Proteins 0.000 abstract 1
102000053602 DNA Human genes 0.000 abstract 1
241000746983 Phleum pratense Species 0.000 abstract 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
238000010367 cloning Methods 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000008030 elimination Effects 0.000 abstract 1
238000003379 elimination reaction Methods 0.000 abstract 1
239000013604 expression vector Substances 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
230000035772 mutation Effects 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Botany (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pathology (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

PL400683A 2002-06-25 2003-06-11 Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pyłku traw Phl p4 PL219272B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02013953		2002-06-25

Publications (2)

Publication Number	Publication Date
PL400683A1 true PL400683A1 (pl)	2013-02-04
PL219272B1 PL219272B1 (pl)	2015-04-30

Family

ID=29797135

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL372423A PL215097B1 (pl)	2002-06-25	2003-06-11	Czasteczka DNA, zawierajacy ja rekombinowany wektor ekspresyjny DNA, organizm zywiciela transformowany taka czasteczka lub wektorem oraz polipeptyd kodowany przez sekwencje takiej czasteczki DNA o wlasciwosciach glównego alergenu pylku Phl p 4 z Phleum pratense
PL400683A PL219272B1 (pl)	2002-06-25	2003-06-11	Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pyłku traw Phl p4

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL372423A PL215097B1 (pl)	2002-06-25	2003-06-11	Czasteczka DNA, zawierajacy ja rekombinowany wektor ekspresyjny DNA, organizm zywiciela transformowany taka czasteczka lub wektorem oraz polipeptyd kodowany przez sekwencje takiej czasteczki DNA o wlasciwosciach glównego alergenu pylku Phl p 4 z Phleum pratense

Country Status (13)

Country	Link
US (3)	US8128935B2 (pl)
EP (2)	EP1515988B1 (pl)
JP (1)	JP2006510346A (pl)
CN (1)	CN100391970C (pl)
AT (1)	ATE550349T1 (pl)
AU (1)	AU2003279352B2 (pl)
BR (1)	BR0312068A (pl)
CA (1)	CA2491038C (pl)
ES (2)	ES2384045T3 (pl)
PL (2)	PL215097B1 (pl)
PT (2)	PT2392591T (pl)
RU (1)	RU2327739C2 (pl)
WO (1)	WO2004000881A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10359351A1 (de)	2003-12-16	2005-07-21	Merck Patent Gmbh	DNA-Sequenz und rekombinante Herstellung von Gruppe-4 Majorallergenen aus Getreiden
AU2011202726B2 (en) *	2003-12-16	2012-04-26	Merck Patent Gmbh	DNA-sequence and recombinant production of group 4 major allergens from cereals
DE10359352A1 (de)	2003-12-16	2005-07-21	Merck Patent Gmbh	DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Lol p 4
AU2013204574B2 (en) *	2003-12-16	2015-02-26	Merck Patent Gmbh	DNA-sequence and recombinant production of group 4 major allergens from cereals
RU2607373C2 (ru) *	2010-01-14	2017-01-10	Мерк Патент Гмбх	Модификации аллергенов группы 6 poaceae (мятликовых), имеющих пониженную аллергенность благодаря мутагенезу пролиновых остатков
IN2014MN01513A (pl) *	2012-02-07	2015-09-11	Jolla Inst Allergy Immunolog

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030135888A1 (en) *	2001-09-26	2003-07-17	Tong Zhu	Genes that are modulated by posttranscriptional gene silencing

2003
- 2003-06-11 PT PT110056207T patent/PT2392591T/pt unknown
- 2003-06-11 EP EP03740216A patent/EP1515988B1/de not_active Revoked
- 2003-06-11 EP EP11005620.7A patent/EP2392591B1/de not_active Expired - Lifetime
- 2003-06-11 JP JP2004514687A patent/JP2006510346A/ja active Pending
- 2003-06-11 WO PCT/EP2003/006092 patent/WO2004000881A1/de not_active Ceased
- 2003-06-11 CA CA2491038A patent/CA2491038C/en not_active Expired - Fee Related
- 2003-06-11 AT AT03740216T patent/ATE550349T1/de active
- 2003-06-11 ES ES03740216T patent/ES2384045T3/es not_active Expired - Lifetime
- 2003-06-11 US US10/518,927 patent/US8128935B2/en not_active Expired - Fee Related
- 2003-06-11 ES ES11005620.7T patent/ES2670573T3/es not_active Expired - Lifetime
- 2003-06-11 PL PL372423A patent/PL215097B1/pl unknown
- 2003-06-11 RU RU2005101744/13A patent/RU2327739C2/ru not_active IP Right Cessation
- 2003-06-11 PL PL400683A patent/PL219272B1/pl unknown
- 2003-06-11 CN CNB038151782A patent/CN100391970C/zh not_active Expired - Fee Related
- 2003-06-11 BR BR0312068-6A patent/BR0312068A/pt not_active Application Discontinuation
- 2003-06-11 AU AU2003279352A patent/AU2003279352B2/en not_active Ceased
- 2003-06-11 PT PT03740216T patent/PT1515988E/pt unknown
2011
- 2011-02-24 US US13/034,210 patent/US9120866B2/en not_active Expired - Fee Related
2014
- 2014-11-21 US US14/550,370 patent/US9556241B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2384045T3 (es)	2012-06-28
WO2004000881A1 (de)	2003-12-31
PL215097B1 (pl)	2013-10-31
ATE550349T1 (de)	2012-04-15
EP1515988B1 (de)	2012-03-21
ES2670573T3 (es)	2018-05-31
CN1665835A (zh)	2005-09-07
US9120866B2 (en)	2015-09-01
RU2327739C2 (ru)	2008-06-27
CA2491038A1 (en)	2003-12-31
RU2005101744A (ru)	2005-06-27
US20120288526A1 (en)	2012-11-15
AU2003279352B2 (en)	2009-09-10
AU2003279352A1 (en)	2004-01-06
PT2392591T (pt)	2018-05-23
PL219272B1 (pl)	2015-04-30
PL372423A1 (pl)	2005-07-25
US8128935B2 (en)	2012-03-06
EP1515988A1 (de)	2005-03-23
EP2392591A1 (de)	2011-12-07
BR0312068A (pt)	2005-03-29
US9556241B2 (en)	2017-01-31
EP2392591B1 (de)	2018-02-21
US20150079120A1 (en)	2015-03-19
CA2491038C (en)	2017-04-25
WO2004000881A9 (de)	2004-02-26
US20060177470A1 (en)	2006-08-10
JP2006510346A (ja)	2006-03-30
CN100391970C (zh)	2008-06-04
PT1515988E (pt)	2012-06-25

Publication	Publication Date	Title
US9346860B2 (en)	2016-05-24	Expression system
AU2007271350B2 (en)	2013-03-21	Small Streptococcus pyogenes antigens and their use
Ohashi et al.	1990	Cloning and sequencing of the gene (tsg56) encoding a type-specific antigen from Rickettsia tsutsugamushi
SE0000514D0 (sv)	2000-02-17	A 52 kDa protein from coagulase negative staphylococci and fragments
KR20070029708A (ko)	2007-03-14	스타필로코커스 아우레우스의 변형 피브로넥틴-결합 단백질
PL400683A1 (pl)	2013-02-04	Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pylku traw PHL P4
TW200716166A (en)	2007-05-01	Lawsonia intracellularis immunological proteins
CN110746496B (zh)	2023-07-07	一种鲍曼不动杆菌的pal重组蛋白及其编码基因和它们的应用
EP0502016B1 (en)	1996-10-02	Novel vaccine
AU6128900A (en)	2001-04-05	Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US8263090B2 (en)	2012-09-11	Variants of group 1 allergens from Poaceae having reduced allergenicity and maintained T-cell reactivity
DE502004012294D1 (de)	2011-04-21	Dna-sequenz und rekombinante herstellung von gruppe-4 majorallergenen aus getreiden
ATE513848T1 (de)	2011-07-15	Phl p 5a-derivate mit reduzierter allergenität und erhaltener t-zellreaktivität
EP0555894B1 (en)	1999-06-16	Whooping cough vaccine
JP3532510B2 (ja)	2004-05-31	組換え豚丹毒菌防御抗原の回収精製法
JP6039648B2 (ja)	2016-12-07	併用ワクチン
AU2013203639A1 (en)	2013-05-02	Small streptococcus pyogenes antiens and their use
HK1004569B (en)	1998-11-27	Novel vaccine